Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study. Issue 6 (June 2021)
- Record Type:
- Journal Article
- Title:
- Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study. Issue 6 (June 2021)
- Main Title:
- Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study
- Authors:
- da Cunha Júnior, Ademar Dantas
Silveira, Marina Nogueira
Takahashi, Maria Emilia Seren
de Souza, Edna Marina
Mosci, Camila
Ramos, Celso Dario
Brambilla, Sandra Regina
Pericole, Fernando Vieira
Prado, Carla M.
Mendes, Maria Carolina Santos
Carvalheira, José Barreto Campello - Abstract:
- Summary: Background & aims: The use of computerized tomography to opportunistically assess body composition has highlighted abnormalities such as low muscle mass and high adiposity may be hidden conditions in cancer patients. However, the role of skeletal muscle (SM), subcutaneous (SAT) and visceral (VAT) adipose tissue glucose uptake measured by 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET)-CT on patient prognostication is unclear. Methods: Patients with multiple myeloma (MM) with satisfactory image frame for assessing body composition and for semi-quantification of SM, SAT and VAT glucose uptakes were included. Plasmatic pro-inflammatory cytokine and adipokine levels were measured. Results: High VAT mean standardized uptake value (SUV) at baseline was associated with shorter event-free survival (EFS) (hazard ratio [HR]: 7.89; 95% confidence interval [CI], 1.58–39.30; P = 0.012) and overall survival (OS) (HR, 15.24; 95% CI, 2.69–86.30; P = 0.002) among patients with newly diagnosed MM, even after adjustment for covariates. The highest tertile of VAT SUV was significantly correlated with worse MM-EFS (HR for the highest vs the lowest tertile 3.71; 95% CI, 1.22–10.56; Ptrend = 0.035) and mortality (HR, 4.41; 95% CI, 1.28–12.77; Ptrend = 0.019). Notably, patients with higher VAT SUV presented with lower VAT area, VAT index, higher SAT SUV, and higher number of individuals with visceral obesity (all P < 0.01). Additionally, we found a negativeSummary: Background & aims: The use of computerized tomography to opportunistically assess body composition has highlighted abnormalities such as low muscle mass and high adiposity may be hidden conditions in cancer patients. However, the role of skeletal muscle (SM), subcutaneous (SAT) and visceral (VAT) adipose tissue glucose uptake measured by 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET)-CT on patient prognostication is unclear. Methods: Patients with multiple myeloma (MM) with satisfactory image frame for assessing body composition and for semi-quantification of SM, SAT and VAT glucose uptakes were included. Plasmatic pro-inflammatory cytokine and adipokine levels were measured. Results: High VAT mean standardized uptake value (SUV) at baseline was associated with shorter event-free survival (EFS) (hazard ratio [HR]: 7.89; 95% confidence interval [CI], 1.58–39.30; P = 0.012) and overall survival (OS) (HR, 15.24; 95% CI, 2.69–86.30; P = 0.002) among patients with newly diagnosed MM, even after adjustment for covariates. The highest tertile of VAT SUV was significantly correlated with worse MM-EFS (HR for the highest vs the lowest tertile 3.71; 95% CI, 1.22–10.56; Ptrend = 0.035) and mortality (HR, 4.41; 95% CI, 1.28–12.77; Ptrend = 0.019). Notably, patients with higher VAT SUV presented with lower VAT area, VAT index, higher SAT SUV, and higher number of individuals with visceral obesity (all P < 0.01). Additionally, we found a negative correlation between VAT mean SUV with leptin (R 2 = 0.20, P = 0.003); no correlations were detected between VAT mean SUV and resistin, tumor necrosis factor (TNF) or interleukin (IL)-6. Conclusions: Functional VAT activity estimated by 18 F-FDG PET-CT is a relevant prognostic factor in MM patients, specifically, a higher VAT SUV might be an early biomarker of cancer cachexia in these patients. … (more)
- Is Part Of:
- Clinical nutrition. Volume 40:Issue 6(2021)
- Journal:
- Clinical nutrition
- Issue:
- Volume 40:Issue 6(2021)
- Issue Display:
- Volume 40, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 40
- Issue:
- 6
- Issue Sort Value:
- 2021-0040-0006-0000
- Page Start:
- 4075
- Page End:
- 4084
- Publication Date:
- 2021-06
- Subjects:
- Cancer -- Cachexia -- Body composition -- Intra-abdominal fat -- PET-CT -- Survival
Critically ill -- Nutrition -- Periodicals
Diet therapy -- Periodicals
Parenteral feeding -- Periodicals
Enteral feeding -- Periodicals
Enteral Nutrition -- Periodicals
Parenteral Nutrition -- Periodicals
Metabolism -- Periodicals
Diétothérapie -- Périodiques
Alimentation parentérale -- Périodiques
Alimentation entérale -- Périodiques
Nutrition -- Périodiques
Diet therapy
Enteral feeding
Nutrition
Parenteral feeding
Electronic journals
Periodicals
Electronic journals
615.854 - Journal URLs:
- http://www.sciencedirect.com/science/journal/02615614 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.clnu.2021.02.010 ↗
- Languages:
- English
- ISSNs:
- 0261-5614
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17325.xml